Publications

Drug Information Group faculty regularly publish articles on a variety of topics in peer-reviewed journals and other educational formats.

Recent Publications (2010 - Present)

  • Gabay M, Kvancz D. Practical application of the Safe to Touch 2020 Consensus Conference on Hazardous Drug Surface Contamination: implementation guidance for health care institutions.  Pharmacy Practice News. July 2021;26-28. https://www.pharmacypracticenews.com/Digital-Editions/Article/07-21/Pharmacy-Practice-News-July-2021/63970
  • Gerberich A, Ipema HJ. A primer on ocular viscosurgical devices. Am J Health Syst Pharm. 2021;zxab228. doi:10.1093/ajhp/zxab228
  • Afanasjea J, Burk M, Cunningham FF, Fanikos J, Gabay M, Hayes GJ, Masters PL, Rodriguez R, Sinnett MJ.  ASHP guidelines on medicat      ion-use evaluation. Am J Health Syst Pharm. 2021;78(2):168-175.
  • Rodriguez R, Touchette D. Statistics in practice: survival analysis and common applications. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2021 Book 1. Critical and Urgent Care. Lenexa, KS: American College of Clinical Pharmacy, 2021:151-157.
  • Touchette DR, Rodriguez R. Part II: Statistics in practice: comparing three or more groups. J Am Coll Clin Pharm. 2021. doi:10.1002/jac5.1403
  • Miles KE, Rodriguez R, Gross AE, Kalil A. Strength of recommendation and quality of evidence for recommendations in current Infectious Diseases Society of America guidelines. Open Forum Infect Dis. 2021. doi:10.1093/ofid/ofab033
  • Gabay M, Johnson P, Fanikos J, Amerine L, Kienle P, Olsen M, Roussel C, Moody ML. Report on 2020 Safe to Touch Consensus Conference on Hazardous Drug Surface Contamination. Am J Health Syst Pharm. 2021 Mar 27:zxab134. doi: 10.1093/ajhp/zxab134.
  • West-Thielke PM, Ipema HJ, Campbell-Lee S, et al. Removal of anti-thymocyte globulin by plasma exchange in ABO-incompatible and positive crossmatch kidney transplant recipients. Transplant Proc. February 9, 2021. https://doi.org/10.1016/j.transproceed.2021.01.010
  • Bursua A, Mudreac A, Koppen L, Larson C, Park YS, Sreedhar R. Effect of default order standardization on opioid prescribing patterns. Jt Comm J Qual Patient Saf. 2021;47(7):431-437.
  • Afanasjeva J, Gabay M, Poznanski T, Kerns S. Transdermal patch administration and magnetic resonance imaging (MRI) – 2020. Hosp Pharm. January 9, 2021. https://doi.org/10.1177%2F0018578720987138
  • Spencer S. Immunotherapy toxicities: early recognition, management, and concerns in the COVID-19 pandemic. Clinical Oncology News. October 12, 2020. https://www.clinicaloncology.com/FDA-Watch/Article/10-20/Immunotherapy-Toxicities/60840
  • Gabay M. RxLegal. The evolving legal landscape of telehealth. Hosp Pharm. October 17, 2020. https://doi.org/10.1177%2F0018578720965428
  • Sarna K. Best practices for monitoring hazardous drug surface contamination: a guidance for health care institutions. Pharmacy Practice News. July 23, 2020. https://www.pharmacypracticenews.com/Review-Articles/Article/07-20/Best-Practices-for-Monitoring-Hazardous-Drug-Surface-Contamination/58875
  • Sarna K. Hyperkalemia management: role of the pharmacist in optimization of carePharmacy Practice News. March 19, 2020. https://www.pharmacypracticenews.com/Clinical/Article/03-20/Hyperkalemia-Management/57443
  • Rodriguez R, Touchette DR. Part II: Statistics in practice: statistics overview. J Am Coll Clin Pharm. 2020;1–6. doi:10.1002/jac5.1214
  • Rodriguez R, Touchette D. Statistics in practice: comparing three or more groups. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2020 Book 1. Critical and Urgent Care. Lenexa, KS: American College of Clinical Pharmacy, 2020:221-225.
  • Rodriguez R, Touchette D. Statistics in practice: statistics overview. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2019 Book 1. Cardiology. Lenexa, KS: American College of Clinical Pharmacy, 2019:166-169.
  • Nathan J, Grossman S, Ness G, Gabay M, Ipema H, Tierno H.  Update on the status of drug information centers in the United States.  Am J Health-Syst Pharm. 2020;77(1):33-38.
  • Sarna KV, Griffin T, Tarlov E, Gerber BS, Gabay MP, Suda KJ.  Trends in gender composition on editorial boards in leading medicine nursing, and pharmacy journals.  J Am Pharm Assoc. 2020;60(4):565-570.
  • Spencer SH, Menard SM, Labedz MZ, Krueger CD, Sarna KV. Enteral tube administration of oral chemotherapy drugs. J Oncol Pharm Pract. 2020;26(3):703-717.
  • Ipema H, Zacher J, Galka E, Nazari J, Varabyeva A, Yu M, Hartke P. Drugs to be used with a filter for preparation and/or administration-2019. Hosp Pharm. 2021;56(2):81-87. doi:10.1177/0018578719867660
  • Miles K, Zacher J. A physician primer: drugs with orphan designations for the treatment of pain conditions. Practical Pain Management. 2019. Available at: https://www.practicalpainmanagement.com/resources/practice-management/physician-primer-drugs-orphan-designations-treatment-pain-conditions?fbclid=IwAR00bFHTLtzYJvpnDRYaDA4H1TZC0Gota6X1Zf1pNmui04XB-POuOmBIaVg
  • Lee M, Saseen J, Beckman E, Coon S, Gabay M, Japs K, Mangan B, McBane S, See S.  ACCP Commentary. Expanding the pharmacist’s scope of practice at the state level: support for board certification within the credentialing process. J Am Coll Clin Pharm. 2019;2(6):694-701.
  • Gabay M.  The Orphan Drug Act: an appropriate approval pathway for treatments of rare diseases?  Hosp Pharm. 2019;54(5):283-284.
  • Gabay M, Hertig JB, Degnan D, Burger M, Yaniv A, McLaughlin M, Moody ML.  Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems – 2018.  Am J Health-Syst Pharm. 2020;77(3):215-220.
  • Gerberich A, Spencer S, Ipema H. National Guideline Clearinghouse is no more – keep calm and search on. Ann Pharmacother. 2019;53(4):434-436.
  • Spencer S. Immunotherapy toxicities: early recognition and management. Pharmacy Practice News. Published September 16, 2019. https://www.pharmacypracticenews.com/Review-Articles/Article/09-19/Immunotherapy-Toxicities-Early-Recognition-and-Management/55937
  • Rodriguez R, Koppen L, Patel YA, Ellinger, LK. Characteristics of shortage-related drug information requests and recommendations from a nationally-serving drug information center. Am J Health Syst Pharm. 2019;76(23):1900-1902. doi: 10.1093/ajhp/zxz230.
  • Sarna KV, Gross AE. Vancomycin versus metronidazole for non-severe Clostridioides difficile infection: are the data adequate to change practice? Ann Pharmacother. 2019.53(8):845-852.
  • Loeser K, Rodriguez R. Abuse-deterrent opioids: regulatory and evidence-based considerations for front-line clinicians. Am J Health Syst Pharm. 2019;76(2):114-118. doi: 10.1093/ajhp/zxy013.
  • Rodriguez R, Fernandez EM. The role of angiotensin II in treatment of refractory distributive shock. Am J Health Syst Pharm. 2019;76(2):101-107. doi: 10.1093/ajhp/zxy014.
  • Rodriguez R. The science of biosimilars and the future of interchangeability. Pharm Pract News. 2019:41-45.
  • Rodriguez R, Cucci M, Kane S, Fernandez E, Benken S. Novel vasopressors in the treatment of vasodilatory shock: a systematic review of angiotensin II, selepressin, and terlipressin. J Intensiv Care Med. 2018. doi: 10.1177/0885066618818460.
  • Rodriguez R. The safety of intravenous drug delivery systems: update on current issues since the 2009 Consensus Development Conference. Hosp Pharm. 2018;53(6):408-414. doi: 10.1177/0018578718798638.
  • Rasmussen JT, Ipema HJ. Formulary considerations for insulins approved through the 505(b)(2) ‘follow-on’ pathway.
  • Spencer S, Majkowski C, Suda KJ. Publication rates and predictors of publication for abstracts presented at American Association of Colleges of Pharmacy (AACP) annual meetings. Am J Pharm Educ. 2018;82(8):6409.
  • Koppen L, Suda K, Rowan S, McGregor J, Evans C. Dentists’ prescribing of antibiotics and opioids to Medicare Part D beneficiaries: medications of high impact to public health. J Am Dent Assoc. 2018;149(8):721-730.
  • Gabay M. RxLegal: a rapid review of right-to-try. Hosp Pharm.2018;53(4):234-235.
  • Gabay M. The prescription drug user fee act: cause for concern? Hosp Pharm. 2018;53(2):88-89.
  • Spencer S, Ipema H, Hartke PKrueger C, Rodriguez R, Gross AE, Gabay M. Intravenous push administration for antibiotics: An alternative method. Hosp Pharm. 2018;53(3):157-169.
  • Gabay M. Biosimilar substitution laws. Hosp Pharm. 2017. 52(8):544-545.
  • Gabay M. Direct and indirect remuneration fees: the controversy continues. Hosp Pharm. 2017;52(11):740-741.
  • Koppen L, Whitaker A, Rosene A, Beckett R. Effect of berberine alone and in combination for the treatment of hyperlipidemia: a systematic review. J Evid Based Complementary Altern Med. 2017;22(4):956-968.
  • Gabay M. The evolution of drug information centers and specialists. Hosp Pharm. 2017;52(7):452-453.
  • Gabay M. 21st Century Cures Act. Hosp Pharm. 2017;52(4):264-265.
  • Gabay M, Smith J, Chavez M, et al. White paper on natural products. Pharmacotherapy. 2017;37(1):e1-e15.
  • Afanasjeva J. Administration of injectable vitamin K orally. Hosp Pharm. 2017;52(9):645-649.
  • Rodriguez R, Kelly B, Moody M. Evaluating the training, responsibilities, and practices of P&T committee members and nonmember contributors. Journal of Managed Care and Specialty Pharmacy. 2017;23(8):868-874.
  • Rodriguez R, Soni R. Psoriatic arthritis: established, newer, and emerging therapies. Practical Pain Management. 2017;17(6). Available at: https://www.practicalpainmanagement.com/pain/myofascial/inflammatory-arthritis/psoriatic-arthritis-established-newer-emerging-therapies.
  • Shah J, Rodriguez R. Are abuse-deterrent opioid products a double-edged sword? Practical Pain Management. 2017;17(4):45-53.
  • Koppen L, Afanasjeva J. A brief history of the FDA’s role in the ongoing effort to ensure safe opioid use. Practical Pain Management. 2017;17(1). Available at: https://www.practicalpainmanagement.com/treatments/pharmacological/opioids/brief-history-fda-role-ongoing-effort-ensure-safe-opioid-use.
  • Afanasjeva J, Hui RL, Spence MM, et al. Identifying subsequent therapies in patients with advanced non-small-cell lung cancer and factors associated with overall survival. Pharmacotherapy. 2016;36(10):1065-1074.
  • Rodriguez R. Comparison of indexing times among articles from medical, nursing, and pharmacy journals. Am J Health Syst Pharm. 2016;73(8):569-575.
  • Gabay M.  Drug prices: is there a need for transparency?  Hosp Pharm. 2016;51(2):132-133.
  • Spencer S, Suda KJ, Smith MJ, Huo Z, Bailey L, Stroupe KT. Erectile dysfunction medication use in veterans eligible for Medicare Part D. J Manag Care Spec Pharm. 2016;22(7):818-824.
  • Bursua A, Hartke PL, Larson CM. Benchmarking and medication error rates. Am J Health Syst Pharm. 2016;73(11):744.
  • Gabay M. Increasing access to naloxone and legal issues. Hosp Pharm. 2016;51(8):633-364.
  • Hartke P, Afanasjeva J. Sports-related pain: topical treatments. Practical Pain Management. 2016;16(4). Available at: http://www.practicalpainmanagement.com/treatments/pharmacological/non-opioids/sports-related-pain-topical-treatments.
  • Hartke PL, Vermeulen LC, Hoffman JM, et al. Accuracy of prescription drug expenditure forecasts published in the AJHP. Am J Health Syst Pharm. 2015;72(19):1642-1648.
  • Koppen L, Phillips J, Papageorgiou R. Analysis of reference sources used in drug-related Wikipedia articles. J Med Libr Assoc. 2015;103(3):140-144.
  • Gabay M.  FAST Generics Act of 2015.  Hosp Pharm. 2016;51(1):42-43.
  • Zych KIpema H. Psoriasis and psoriatic arthritis: update in management. Specialty Pharmacy Continuum. January/February 2016. Available at: http://www.specialtypharmacycontinuum.com/download/psoriasis_spc0116_WM.pdf.
  • Ghaibi S, Ipema HJGabay MG. ASHP guideline on the pharmacist’s role in providing drug information. Am J Health Syst Pharm. 2015;72(7):573-577.
  • Gabay MThe Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning: 2015.
  • Gabay M, McKeever AL. Introduction to drug information practice. In: Gabay M, ed. The Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning; 2015:1-10.
  • Rodriguez RW. Analysis and interpretation of noninferiority trials. In: Gabay M, ed. The Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning: 2015;195-212.
  • Gabay M, Grando Holman Y. Academic detailing and industry relationships. In: Gabay M, ed. The Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning: 2015;409-424.
  • Ipema HJ, Tanzi MG. Medical writing and peer review. In: Gabay M, ed. The Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning; 2015:
  • Gabay MP, Wirth SM, Stachnik JM, Overley CL, Long KE, Bressler LR, Villano JL.  Oral targeted therapies and central nervous system (CNS) metastases.  CNS Drugs. 2015;29(11):935-952.
  • Gabay M.  Regulation of internet pharmacies: a continual challenge.  Hosp Pharm. 2015;50(8):681-682.
  • Gabay M. Providing feedback to colleagues: a continual challenge. Hosp Pharm. 2015;50(4):259-260.
  • Gabay M. Prescription drug monitoring programs. Hosp Pharm. 2015;50(4):277-278.
  • Reddy A, Gabay M. Brintellix (vortioxetine) review. Illinois Pharmacist. 2014;76(3):26-29.
  • Gabay M. The Drug Quality and Security Act. Hosp Pharm. 2014;49(7):615-616.
  • Gabay M. USP : Handling hazardous drugs. Hosp Pharm. 2014;49(9):811-812.
  • Krueger C. New treatments for rheumatoid arthritis. Specialty Pharmacy Continuum. 2014;4(3):8-10.
  • Rodriguez RW. Off-label uses of alvimopan and methylnaltrexone. Am J Health Syst Pharm. 2014;71(17):1450-1455.
  • Letarte N, Gabay MP, Bressler LR, Long KE, Stachnik JM, Villano JL. Analyzing temozolomide medication errors: potentially fatal. J Neurooncol. 2014;120(1):111-115.
  • Fisseha N, Rodriguez RIpema H. Olysio (simeprevir) Review. Illinois Pharmacist. 2014;26(2):26-27.
  • UIC Drug Information Group. Light-sensitive injectable prescription drugs. Hosp Pharm. 2014;49(2):136-163.
  • Gabay M. Federal controlled substances act:  dispensing requirements, electronic prescriptions, and fraudulent prescriptions. Hosp Pharm. 2014;49(3):244-246.
  • Gabay M. A step forward: review of the new California Provider Status law. Hosp Pharm. 2014;49(5):435-436.
  • Rodriguez RW. Delay in indexing of articles published in major pharmacy practice journals. Am J Health Syst Pharm. 2014;71(4):321-324.
  • Rodriguez RW. How safe is epidural steroid injection? Examining drug-related factors. Practical Pain Management. 2014;14(2):31-35. Available at: http://www.practicalpainmanagement.com/treatments/interventional/injections/how-safe-epidural-steroid-injection-examining-drug-related.
  • Rodriguez R, Ellinger LK. Rheumatoid arthritis treatment guidelines updated (update). In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York: McGraw-Hill; 2013.
  • Rodriguez RW, Staley B, Hatton RC. Evaluating incorporation of drug restrictions into computerized drug order entries after transition to an electronic health record. Hosp Pharm. 2013;48(7):568-573.
  • Stachnik JM, Krueger CD. Infertility in women. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2013 Book 2. Special Populations. Lenexa, KS: American College of Clinical Pharmacy, 2013:61-76.
  • Gabay M, Boucher BA.  An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis.  Pharmacotherapy. 2013;33(9):935-955.
  • Gabay M.  Federal controlled substances act: ordering and recordkeeping.  Hosp Pharm. 2013;48(11):919-921.
  • Gabay M.  Federal controlled substances act: controlled substances prescriptions.  Hosp Pharm. 2013;48(8):644-645.
  • Gabay M.  The federal controlled substances act:  schedules and pharmacy registration.  Hosp Pharm. 2013;48(6):473-474.
  • Gabay M.  Expanding the definition of nonprescription drugs: potential impact on pharmacists.  Hosp Pharm. 2013;48(3):198-199.
  • Krueger C. Ask The Expert: I have recently read a lot on twitter that NSAIDs cause more deaths than opioids. Can you clarify if this is true? Practical Pain Management. 2013;13(10). Available at: http://www.practicalpainmanagement.com/treatments/pharmacological/opioids/ask-expert-do-nsaids-cause-more-deaths-opioids
  • Ipema HJ. Use of oral vitamin K for prevention of late vitamin K deficiency bleeding in neonates when injectable vitamin K is not available. Ann Pharmacother. 2012;46(6):879-883.
  • Ipema HJ, Tanzi MG. Use of topical tranexamic acid and aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother. 2012:46(1):97-107.
  • UIC Drug Information Group. Drugs that require filtration for preparation or administration. Hosp Pharm. 2012;47(5):351-359.
  • Phillips JA, Gabay MP, Ficzere C, Ward KE. Curriculum and instructional methods for drug information, literature evaluation, and biostatistics: survey of US pharmacy schools. Ann Pharmacother. 2012;46(6):793-801.
  • Gabay MP, Thakkar JP, Stachnik JM, Woelich SK, Villano JL. Intra-CSF administration of chemotherapy medications. Cancer Chemother Pharmacol. 2012;70(1):1-15.
  • Gabay M. Tech-check-tech: an overview. Hosp Pharm. 2012;47(6):444-445.
  • Gabay M. Drug importation: where do we stand? Hosp Pharm. 2012;47(2):110-111.
  • Stachnik J, Gabay M. Biologics in pediatrics. In: Field M, Boat T, eds. Supporting the Review of Best Pharmaceuticals for Children Act and Pediatric Research. Institute of Medicine of the National Academies. Released February 29, 2012. Available at: http://www.iom.edu/Reports/2012/Safe-and-Effective-Medicines-for-Children.aspx.
  • Lodolce AE, Krueger CD. Managing anemia in patients with chronic kidney disease. Pharmacy Practice News. 2012;39. Available at: http://www.pharmacypracticenews.com/download/Anemia_ppn0612_WM.pdf.
  • Krueger C. Methadone for pain management. Practical Pain Management. 2012;12(2). Available at: http://www.practicalpainmanagement.com/treatments/pharmacological/opioids/methadone-pain-management.
  • Ghaibi S, Ipema H. Proper disposal of fentanyl patches: what patients need to know. Practical Pain Management. 2012;12(10). Available at: http://www.practicalpainmanagement.com/treatments/pharmacological/opioids/proper-disposal-fentanyl-patches-what-patients-need-know.
  • Segreti J, Garcia-Houchins S, Gorski L, Moureau N, Shomo J, Zack J, Stachnik J, Tanzi M, Moody ML. Consensus conference on prevention of central line-associated bloodstream infections: 2009. J Infus Nurs. 2011;34(2):126-133.
  • Hong IS, Ipema HJ, Gabay MP, Lodolce AE. Medication repurposing: new uses for old drugs. J Pharm Technol. 2011;27(3):132-140.
  • Gabay M. Pharmacists and prescriptive authority. Hosp Pharm. 2011;46(11):852-853.
  • Gabay M. FDA citizen petition process. Hosp Pharm. 2011;46(8):572-573.
  • Gabay M. Pharmacist conscience clauses: continuing debate. Hosp Pharm. 2011;46(5):330-331.
  • Gabay M. Emily’s law: requiring minimum education and training standards for pharmacy technicians. Hosp Pharm. 2011;46(2):103-104.
  • Ipema HJ, Lodolce AE, Mancuso CE. Survey of drug information activities of ASHP-accredited pharmacy practice residency programs. Am J Health Syst Pharm. 2011;68(13):1194-1195.
  • Burda AT, Ipema HJ, Wahl MS. Self-treatment of acetaminophen overdose with dietary-supplement acetylcysteine. Am J Health Syst Pharm. 2011;68(9):786-787.
  • Krueger C.  Medications for chronic pain – other agents. Practical Pain Management. 2011;11(5):90-99. Available at: http://www.practicalpainmanagement.com/treatments/pharmacological/medications-chronic-pain-other-agents
  • Krueger C. Management of warfarin therapy. Pharmacy Practice News. 2011;38:43-50 (updated 2012). http://www.pharmacypracticenews.com/download/warfarin_therapy_ppn1212_WM.pdf.
  • Gabay M. Academic detailing and the IDEA act. Hosp Pharm. 2010;45(11):839-840.
  • Hong I, Gabay M, Lodolce A. Safety concerns involving transdermal patches and magnetic resonance imaging (MRI). Hosp Pharm. 2010;45(10):771-778.
  • Mancuso CE, Gabay MP, Steinke LM, VanOsdol SJ. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1. Ann Pharmacother. 2010;44(7-8):1240-1249.
  • Ellinger LK, Ipema HJ, Stachnik JM. Efficacy of metformin and topiramate in prevention and treatment of antipsychotic-induced weight gain. Ann Pharmacother. 2010;44(4):668-679.
  • Krueger C.  Management of epidermal growth factor inhibitor-induced dermatologic toxicity.  Pharmacy Practice News. 2010;37:16-20. Available at: http://www.pharmacypracticenews.com/download/epidermalgrowth_ppn0410_WM.pdf.